COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior

Corona Virus Infection Clinical Trial

Official title:

COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04377581
• Other study ID #: STUDY00014798
• Status: Completed
• Start date: April 9, 2020
• Est. completion date: July 10, 2020

Study information

• Verified date: July 2020
• Source: Milton S. Hershey Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Participants are invited to include detailed free-text answers to make sure their COVID-19 experiences are heard.

Description:

The survey is available online in 23 languages. Free-text responses in native languages are highly encouraged. A robust global response will not only provide invaluable information to inform clinicians, healthcare institutions and governments about how to optimize the content and venue of COVID-19 messaging, but will help write a Story of COVID in the words and languages of people from all over the world.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18251
• Est. completion date: July 10, 2020
• Est. primary completion date: July 10, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age

Exclusion Criteria:

• Below 18 years of age

Related Conditions & MeSH terms

• Corona Virus Infection
• Coronavirus Infections
• Demography
• Global Health
• News
• Pandemics
• Perception
• Public Health
• Severe Acute Respiratory Syndrome

Locations

Country	Name	City	State
United States	Penn State College of Medicine	Hershey	Pennsylvania

Sponsors (5)

Lead Sponsor	Collaborator
Milton S. Hershey Medical Center	The College of Healthcare Information Management Executives (CHIME), The Department of Family and Community Medicine, Penn State College of Medicine, The Huck Institutes of the Life Sciences, The Social Science Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Knowledge and Confidence in Knowledge of COVID-19	Binary knowledge measures (true/false questions pertaining to COVID-19) each have a corresponding 5-point confidence score, the inverse of which generates a weighting variable. Weighted knowledge scores will be analyzed via a generalized linear mixed-methods effects model with a logistic link function and a random effect for the participant, generating a probability of correct response from 0 to 1.0.	Through study completion, an average of 3 months.
Primary	Beliefs about the effectiveness of public health recommendations	Participants are asked, "Do you think that following these CDC recommendations will decrease the spread of COVID-19 in your community?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.	Through study completion, an average of 3 months.
Primary	Intent to comply with public health recommendations	Participants are asked, "Will you follow these recommendations?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.	Through study completion, an average of 3 months.
Primary	Perception of Risk of COVID-19 and other health threats	Participants are asked, "How likely is it that you will be diagnosed with any of the following diseases over the next year?" and rate their perceived likelihood of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, very unlikely; Maximum: 5, very likely.; Participants are asked, "How serious do you think infection with any of the following diseases would be (or is) to your own personal health?" and rate their perceived seriousness of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, Not at all Serious; Maximum: 5, Very Serious	Through study completion, an average of 3 months.
Primary	Perceptions of trust in common health information sources	Participants are asked the extent to which they trust common information sources: The World Health Organization, The U.S. Centers for Disease Control and Prevention, the European Commission, the participant's national government, the participant's local government, and the participant's personal healthcare provider. Participants rate on a 5 point scale. Minimum: 1, Not at all; Maximum: 2, Completely. (As these sources are not recognized in all places, participants may select "Not Applicable" in lieu of ranking.	Through study completion, an average of 3 months.
Primary	Single most trusted news source	Participants are asked to identify their single most trusted source of news through selection from a pre-generated list or via free-text.	Through study completion, an average of 3 months.
Secondary	Intention to change consumption of news because of COVID-19 (yes/no)	Participants are asked if COVID-19 will change how they consume news (y/n)	Through study completion, an average of 3 months.
Secondary	For participants who will change their news consumption, in what way will they change?	Participants who answer, "Yes" to Outcome 7 are asked to provide a free-text response to describe how their consumption of news will change.	Through study completion, an average of 3 months.
Secondary	Secondary information sources	Participants are asked to identify all other sources of information via selection from pre-generated menu or free-text.	Through study completion, an average of 3 months.
Secondary	Concerns about COVID-19	Free-text response invited to describe their concerns regarding COVID-19.	Through study completion, an average of 3 months.